AH5-28268-95982
3 vaccinations
4 coded responses
37 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 104 / NY
- Registered
- 2021-08-13
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Hispanic or Latino
Registered dependents
GE9-26671-00375
Child or adolescent in my care · Male · 2022-02-12
Timeline
-
2021-08-13
Registered in v-safe
-
2021-08-13
Dose 1 — Pfizer-BioNTech
- 2021-08-13
-
2021-08-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-08-15
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: Fair · Fatigue or tirednessFree text: Swollen lymph node under armMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-16
- 2021-08-17
- 2021-08-18
- 2021-08-19
- 2021-08-20
- 2021-08-27
-
2021-09-03
Dose 2 — Pfizer-BioNTech
- 2021-09-03
-
2021-09-04
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Swollen lymph nodes under my armMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Fatigue or tirednessAdult check-in
- 2021-09-06
- 2021-09-07
- 2021-09-09
- 2021-09-10
- 2021-09-17
- 2021-09-24
- 2021-10-01
- 2021-10-08
- 2021-10-15
- 2021-12-03
-
2022-02-11
Dose 3 — Pfizer-BioNTech
-
2022-02-12
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-02-13
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Swollen lymph node lump under armMedDRA releases: 2024-11 · check-in free text available
-
2022-02-14
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Fatigue or tiredness, NauseaFree text: Swollen lymph nodeMedDRA releases: 2024-11 · check-in free text available
-
2022-02-15
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Swelling · Headache, Fatigue or tirednessAdult check-in
- 2022-02-16
- 2022-02-17
- 2022-02-18
- 2022-02-25
- 2022-03-04
- 2022-03-11
- 2022-03-18
- 2022-03-25
- 2022-05-13
- 2022-08-14
- 2023-02-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-13 | Pfizer-BioNTech | No |
| 2 | 2021-09-03 | Pfizer-BioNTech | No |
| 3 | 2022-02-11 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Swollen lymph node under arm
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen lymph nodes under my arm
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen lymph node lump under arm
Systemic reaction (other): Swollen lymph node
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Lymphadenopathy | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release